IDMA strongly advises the NPPA to apply prospective batch pricing in order to reduce overcharging and ensure ease of doing business

The Indian Drug Manufacturers' Association (IDMA) has encouraged the National Pharmaceutical Pricing Authority (NPPA) to apply prospective batch pricing to eliminate overcharging and ensure business comfort...

How to Overcome Barriers to Entry in the Pharmaceutical Export Market

In businesses like the pharmaceutical industry, where producers make vast numbers of small items, economies of scale are crucial.

US FDA Approves Krystal Biotech's skin disorder gene therapy For Patients

The US Food and Drug Administration on Friday approved Krystal Biotech Inc's topical gene therapy for patients with a genetic skin disorder, making it the first-of-its kind treatment for epidermolysis bullosa. The therapy, Vyjuvek, has been...

Strides Pharma Science Receives an EIR from the US FDA for its Puducherry Facility

Strides Pharma Science Ltd announced this week that the US Food and Drug Administration (FDA) has issued an establishment inspection report (EIR) for its Puducherry manufacturing facility. The US Food and Drug Administration issues an EIR upon...

Enveric Biosciences to Get US Patent for Novel Psilocin Prodrug

Enveric Biosciences, Inc., a biotechnology company, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application involving EB-373, the company's new chemical entity (NCE) psilocin...

Debiopharm Launches phase 1/2 Combination Trial to Investigate A Brain-Penetrant Selective WEE1 inhibitor for Brain Cancer Patients

Debiopharm, a privately held Swiss biopharmaceutical company aiming to establish tomorrow's standards of care to cure cancer and infectious diseases, has announced the start of an open-label phase 1/2 study evaluating Debio 0123, a brain-penetrant...

Medtronic Invests Rs. 3,000 crore To Expand its Hyderabad R&D Facility

edtronic plc, the global leader in healthcare technology, has announced an investment of approximately Rs. 3,000 crore (more than US$ 350 million) to expand the Medtronic Engineering & Innovation Centre (MEIC) in Hyderabad, in a significant step...

Modality Solutions, CSafe Collaborates to Provide Integrated, end-to-end Cold Chain Solution for Cell and Gene Therapies

Modality Solutions, a trusted cold chain engineering partner for leading biopharmaceutical companies, and CSafe, the market leader in providing a comprehensive suite of thermal shipping solutions for the biopharmaceutical cold chain, have announced..

AstraZeneca's Tagrisso, Chemo combination shows Promise in lung cancer trial

Tagrisso, a cancer medicine developed by AstraZeneca, was used with chemotherapy to treat patients with a kind of lung cancer in a late-stage experiment, the firm announced later this week.

Emcure Pharmaceuticals Launches Injectable To Treat Iron Deficiency In India

Emcure Pharmaceuticals Limited (EPL) announced the launch of Orofer FCM 750, a new parenteral iron brand containing Ferric carboxymaltose (FCM). The new dosage variant is intended to provide a more effective and convenient option for patients with...

© 2025 India Pharma Outlook. All Rights Reserved.